6642|666|Public
5|$|Cholesterol {{levels may}} be {{determined}} {{as part of}} health screening for health insurance or occupational health, when the external physical signs such as xanthelasma, xanthoma, arcus are noticed, symptoms of cardiovascular disease develop, or a family member {{has been found to}} have FH. A pattern compatible with hyperlipoproteinemia type IIa on the Fredrickson classification is typically found: raised level of total cholesterol, markedly raised level of low-density lipoprotein (LDL), normal level of <b>high-density</b> <b>lipoprotein</b> (HDL), and normal level of triglycerides. Total cholesterol levels of 350–550 mg/dL are typical of heterozygous FH while total cholesterol levels of 650–1000 mg/dL are typical of homozygous FH. The LDL is typically above the 75th percentile, that is, 75% of the healthy population would have a lower LDL level. Cholesterol levels can be drastically higher in people with FH who are also obese.|$|E
25|$|Methods to {{increase}} <b>high-density</b> <b>lipoprotein</b> (HDL) particle concentrations, {{which in some}} animal studies largely reverses and remove atheromas, are being developed and researched.|$|E
25|$|Adding {{testosterone}} to {{hormone therapy}} {{has a positive}} effect on sexual function in postmenopausal women, although it may be accompanied by hair growth, acne and a reduction in <b>high-density</b> <b>lipoprotein</b> (HDL) cholesterol. These side effects diverge depending on the doses and methods of using testosterone.|$|E
40|$|Native and {{recombined}} lipoproteins {{have been}} studied by 31 P nuclear magnetic resonance spectroscopy. Very low-, low-, and <b>high-density</b> <b>lipoproteins</b> exhibited characteristic spectra. The main resonances were assigned to phosphatidylcholine and sphingomyelin. Relaxation times for these phospholipids were separately measured in low-density <b>lipoproteins</b> and <b>high-density</b> <b>lipoproteins.</b> The effect of paramagnetic ions (Eu+++) on the nuclear magnetic resonance spectrum of <b>high-density</b> <b>lipoproteins</b> is reported...|$|R
50|$|Phospholipid {{transfer}} protein (PLTP) exchanges phospholipids between <b>lipoproteins</b> and remodels <b>high-density</b> <b>lipoproteins</b> (HDLs).|$|R
5000|$|Einstein {{researchers}} {{demonstrated the}} association between reduced levels of <b>high-density</b> <b>lipoproteins</b> (HDL), or [...] "good" [...] cholesterol, and heart disease.|$|R
25|$|Cholesterol is {{delivered}} into the vessel wall by cholesterol-containing low-density lipoprotein (LDL) particles. To attract and stimulate macrophages, the cholesterol must {{be released from}} the LDL particles and oxidized, a key step in the ongoing inflammatory process. The process is worsened if there is insufficient <b>high-density</b> <b>lipoprotein</b> (HDL), the lipoprotein particle that removes cholesterol from tissues and carries {{it back to the}} liver.|$|E
25|$|Vaisar et al. uses shotgun {{proteomics}} to implicate protease inhibition and complement activation in the antiinflammatory {{properties of}} <b>high-density</b> <b>lipoprotein.</b> In {{a study by}} Lee et al., higher expression level of hnRNP A2/B1 and Hsp90 were observed in human hepatoma HepG2 cells than in wild type cells. This led to a search for reported functional roles mediated in concert by both these multifunctional cellular chaperones.|$|E
25|$|Health risks can be {{produced}} by long-term use or excessive doses of AAS. These effects include harmful changes in cholesterol levels (increased low-density lipoprotein and decreased <b>high-density</b> <b>lipoprotein),</b> acne, high blood pressure, liver damage (mainly with most oral AAS), and dangerous changes {{in the structure of}} the left ventricle of the heart. Conditions pertaining to hormonal imbalances such as gynecomastia and testicular size reduction may also be caused by AAS.|$|E
30|$|Plasma total cholesterol, <b>high-density</b> <b>lipoproteins</b> (HDL), and {{triglyceride}} {{levels were}} estimated by using cholesterol and triglyceride kits, span diagnostics Ltd., India. The assays were performed {{in accordance with}} the manufacturer’s instructions.|$|R
50|$|<b>High-density</b> <b>lipoproteins</b> {{are created}} when a protein in the bloodstream, Apolipoprotein A1 (apoA1), {{combines}} with cholesterol and phospholipids. The cholesterol and phospholipids used to form HDL originate from inside cells but are transported {{out of the}} cell into the blood via the ABCA1 transporter. People with Tangier disease have defective ABCA1 transporters resulting in a greatly reduced ability to transport cholesterol out of their cells, which leads to an accumulation of cholesterol and phospholipids in many body tissues, which can cause them to increase in size. Reduced blood levels of <b>high-density</b> <b>lipoproteins</b> is sometimes described as hypoalphalipoproteinemia.|$|R
5000|$|SCARB1. SR-BI can {{interact}} {{not only with}} oxidized LDL but also with normal LDL and <b>high-density</b> <b>lipoproteins</b> (HDL). Recent {{studies have indicated that}} SR-BI {{is likely to be the}} major receptor involved in HDL metabolism in mice and humans.|$|R
25|$|Low-density {{lipoprotein}} (LDL) {{are one of}} {{the five}} major groups of lipoprotein which transport all fat molecules around the body in the extracellular water. These groups, from least dense, compared to surrounding water, (largest particles) to most dense (smallest particles), are chylomicrons (aka ULDL by the overall density naming convention), very low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), low-density lipoprotein and <b>high-density</b> <b>lipoprotein</b> (HDL). LDL delivers fat molecules to the cells and can drive the progression of atherosclerosis if they become oxidized within the walls of arteries.|$|E
25|$|Of the {{components}} of the cardiometabolic syndrome, only the prevalence of dyslipidemia has declined in the United States. Between 1999 and 2010, the percentage of U.S. adults with high total cholesterol declined from approximately 18% to 13%. However, according to the American Heart Association, nearly half of U.S. adults today (44%) are still at increased risk for atherosclerotic disease because their levels of total cholesterol are elevated (200mg/dL or higher). Of these 98.8 million individuals with elevated cholesterol, 33.6 million have high cholesterol (240mg/dL or above), and 71.3 million have low-density lipoprotein (LDL) cholesterol levels of 130mg/dL or higher. In addition, approximately 19% of U.S. adults have low levels of <b>high-density</b> <b>lipoprotein</b> (HDL) cholesterol, and one-third have elevated triglycerides. Finally, dyslipidemia affects the vast majority (up to 97%) of individuals with diabetes and contributes to their elevated risk for cardiovascular disease.|$|E
25|$|Regular, brisk {{exercise}} {{of any kind}} can improve confidence, stamina, energy, weight control and life expectancy and reduce stress. It can also {{reduce the risk of}} coronary heart disease, strokes, diabetes, high blood pressure, bowel cancer and osteoporosis. Scientific studies have also shown that walking, besides its physical benefits, is also beneficial for the mind, improving memory skills, learning ability, concentration and abstract reasoning, as well as ameliorating spirits. Sustained walking sessions for a minimum period of thirty to sixty minutes a day, five days a week, with the correct walking posture, reduce health risks and have various overall health benefits, such as reducing the chances of cancer, type 2 diabetes, heart disease, anxiety disorder and depression. Life expectancy is also increased even for individuals suffering from obesity or high blood pressure. Walking also improves bone health, especially strengthening the hip bone, and lowering the harmful low-density lipoprotein (LDL) cholesterol, and raising the useful <b>high-density</b> <b>lipoprotein</b> (HDL) cholesterol. Studies have found that walking may also help prevent dementia and Alzheimer's.|$|E
2500|$|<b>High-density</b> <b>lipoproteins</b> (HDL) collect fat {{molecules}} (phospholipids, cholesterol, triglycerides, etc.) {{from the}} body's cells/tissues, {{and take it}} back to the liver. HDLs are sometimes referred to as [...] "good" [...] lipoprotein because higher concentrations correlate with low rates of atherosclerosis progression and/or regression.|$|R
40|$|Normal human serum and a {{fraction}} rich in lipoprotein, Cohn fraction IV 1, {{have been shown}} in previous studies to detoxify native endotoxin by decreasing lethality for mice, fever in rabbits, and by the alteration of the characteristic endotoxin-anti-endotoxin precipitin pattern in gels. These studies are extended herein and document the ability of normal human serum and fraction IV 1 to neutralize the induction of hypotension in rabbits by viable gram-negative bacilli. Further fractionation of serum, using an ultracentrifugal flotation method for producing lipoprotein-free human serum and purified <b>high-density</b> <b>lipoproteins,</b> revealed the lipoprotein-free fraction {{to be capable of}} inhibiting endotoxin hypotensive activity and to alter diffusion of endotoxin in gels. On the other hand, the purified <b>high-density</b> <b>lipoproteins</b> failed to negate either activity...|$|R
40|$|Reverse {{cholesterol}} transport (RCT), a key {{function of}} <b>high-density</b> <b>lipoproteins</b> (HDL), prevents excess cholesterol in tissues. A study {{in this issue}} (Lim et al., 2013) suggests that lymphatic vessels are critical for normal RCT and mediate the active trans-endothelial transport of HDL via the HDL receptor SR-BI...|$|R
25|$|Carotid IMT {{has been}} {{measured}} in numerous epidemiological and clinical studies. These have shown associations with numerous risk factors, including {{type 2 diabetes}} and impaired glucose tolerance, familial hypercholesterolemia, <b>high-density</b> <b>lipoprotein</b> cholesterol (HDL-C) and triglycerides, rheumatoid arthritis, non-alcoholic fatty liver disease, and air pollution. Since the 1990s, some small and larger scale clinical trials of lifestyle and pharmaceutical interventions have also used carotid artery IMT as a surrogate endpoint for evaluating the regression and/or progression of atherosclerotic cardiovascular disease. However the appropriateness of carotid IMT {{in this context is}} uncertain. Although carotid intima-media thickness is strongly associated with atherosclerosis, thickening of the intima-media may not always be due to atherosclerosis. Intima-medial thickening is a complex process, depending on a variety of factors, including local hemodynamics, blood pressure, shear stress and circumferential tensile stress. Changes in shear stress may adversely affect endothelial function and particle residence time, affecting the delivery and transport of potentially atherogenic particles into the arterial wall and consequent plaque formation. Blood pressure may affect IMT through blood vessel remodelling or wall hypertrophy in response to altered circumferential stress. Variations in IMT between different locations, such as the inflow side of branches, the inner curvature at bends and opposite the flow divider at bifurcations may reflect differences in local hemodynamic forces. However, an IMT greater than 0.9-1mm is highly likely to be indicative of atherosclerosis and increased risk of cardiovascular disease. Often, the measurement of the IMT is measured in three locations: in the common carotid (typically at one cm proximal to the flow divider), at the bifurcation, and in the internal carotid artery. IMT measurements of the far (deeper) wall, by ultrasound, are generally considered more reliable than measurements performed on the near (more superficial) wall; although measurement of both near and far wall IMT has also been advocated.|$|E
500|$|A high {{dietary intake}} of sugar (in this case, sucrose or disaccharide) can {{substantially}} {{increase the risk}} of heart and vascular diseases. According to a Swedish study of [...] undertaken by Lund University and Malmö University College, sugar was associated with higher levels of bad blood lipids, causing a high level of small and medium low-density lipoprotein (LDL) and reduced <b>high-density</b> <b>lipoprotein</b> (HDL). In contrast, the amount of fat eaten did not affect the level of blood fats. Incidentally quantities of alcohol and protein were linked to an increase in the good HDL blood fat.|$|E
2500|$|<b>High-density</b> <b>lipoprotein</b> (HDL) {{are one of}} {{the five}} major g lipoproteins.|$|E
40|$|In {{the past}} few decades, {{consumption}} of added sugars has increased dramatically. Studies have linked high sugar intake with increased risk {{for a number of}} diseases. Importantly, fructose, a component of sugar, has been linked with the development of features of metabolic syndrome. This study determined if single nucleotide polymorphisms in genes involved in fructose transport (solute carrier family 2 facilitated glucose transporter, member 2 (SLC 2 A 2) and solute carrier family 2 facilitated glucose/fructose transporter, member 5 (SLC 2 A 5)) and metabolism (ketohexokinase (KHK)) affect inter-individual variability in metabolic phenotypes, such as increased serum uric acid levels. The influence of SLC 2 A 2, SLC 2 A 5, and KHK SNPs on metabolic phenotypes was tested in 237 European Americans and 167 African Americans from the Pharmacogenomic Evaluation and Antihypertensive Responses (PEAR) study. Using baseline untreated fasting data, associations were considered significant if p≤ 0. 005. These SNPs were then evaluated for potential replication (p≤ 0. 05) using data from the Genetic Epidemiology of Responses to Antihypertensives (GERA) studies. SLC 2 A 5 rs 5438 was associated with an increase in serum uric acid in European American males. However, we were unable to replicate the association in GERA. The minor allele of SLC 2 A 2 rs 8192675 showed an association with lower <b>high-density</b> <b>lipoproteins</b> in European Americans (A/A: 51. 0 mg/dL, A/G: 47. 0 mg/dL, G/G: 41. 5 mg/dL, p = 0. 0034) in PEAR. The association between rs 8192675 and lower <b>high-density</b> <b>lipoproteins</b> was replicated in the combined European American GERA study samples (A/A: 47. 6 mg/dL, A/G: 48. 6 mg/dL, G/G: 41. 9 mg/dL, p = 0. 0315). The association between SLC 2 A 2 rs 8192675 and <b>high-density</b> <b>lipoproteins</b> suggests the polymorphism {{may play a role in}} influencing <b>high-density</b> <b>lipoproteins</b> and thus metabolic risk of cardiovascular disease...|$|R
40|$|Macrophages in {{atherosclerotic}} plaques are activated, {{inflammatory cells}} that directly {{contribute to the}} disease process. De Nardo et al. (2013), now report that <b>high-density</b> <b>lipoproteins</b> (HDL) can reprogram macrophages to be less inflammatory through an ATF 3 -dependent pathway, providing another mechanistic basis for the atheroprotective properties of HDL...|$|R
5000|$|While {{circulating}} in blood, chylomicrons exchange components with <b>high-density</b> <b>lipoproteins</b> (HDL). The HDL donates apolipoprotein C-II (APOC2) and apolipoprotein E (APOE) to the nascent chylomicron and, thus, converts it to a mature chylomicron (often referred to simply as [...] "chylomicron"). APOC2 is the coenzyme for lipoprotein lipase (LPL) activity.|$|R
2500|$|Dyslipidemia: {{triglycerides}} (TG): ≥ 1.695nbsp&mmol/L [...] and <b>high-density</b> <b>lipoprotein</b> cholesterol (HDL-C) ≤ 0.9nbsp&mmol/L (male), ≤ 1.0nbsp&mmol/L (female) ...|$|E
2500|$|PON1 (paraoxonase 1) {{is also a}} major anti-atherosclerotic {{component}} of <b>high-density</b> <b>lipoprotein</b> (HDL). [...] The PON1 gene is activated by PPAR-γ, which increases synthesis and release of paraoxonase1 enzyme from the liver, reducing atherosclerosis.|$|E
2500|$|There are strong, consistent, and graded {{relationships}} between saturated fat intake, blood cholesterol levels, {{and the mass}} occurrence of cardiovascular disease. The relationships are accepted as causal. Abnormal blood lipid levels, that is high total cholesterol, high levels of triglycerides, high levels of low-density lipoprotein (LDL, [...] "bad" [...] cholesterol) or low levels of <b>high-density</b> <b>lipoprotein</b> (HDL, [...] "good" [...] cholesterol) cholesterol are all associated with increased {{risk of heart disease}} and stroke.|$|E
40|$|To {{evaluate}} {{the effects of}} dietary phospholipids on plasma lipoproteins in the postprandial phase six normolipidemic men were fed alternatively a test meal rich in phosphatidylcholine and a control meal low in phosphatidylcholine. Plasma very low-density lipoproteins, low-density <b>lipoproteins,</b> and <b>high-density</b> <b>lipoproteins</b> were isolated at 2, 4 and 6 h after the meals. The changes in lipoprotein cholesterol, triacylglycerol, and phospholipid after feeding the phospholipid-rich meal were indistinguishable from those after the low-phospholipid meal. The phospholipid composition in <b>high-density</b> <b>lipoproteins</b> was also unchanged. The amount of phosphatidylcholine used in this trial was approximately 10 -fold higher than that found in the normal Swedish diet. It is therefore concluded that the normal dietary intake of phosphatidylcholine has little influence on the plasma lipoprotein parameters measured in the present study...|$|R
40|$|Hotsite of {{proteomics}} metabolomics developped by: Braz J Med Biol Res, December 2010, Volume 43 (12) 1135 - 1142 doi: 10. 1590 /S 0100 - 879 X 2010007500136 Reversible flow of cholesteryl ester between <b>high-density</b> <b>lipoproteins</b> and triacylglycerol-rich particles is modulated by the {{fatty acid}} composition and concentration of triacylglycerol...|$|R
40|$|Background and PurposeMonocyte-derived macrophages are {{critical}} {{in the development of}} atherosclerosis and can adopt a wide range of functional phenotypes depending on their surrounding milieu. <b>High-density</b> <b>lipoproteins</b> (HDLs) have many cardio-protective properties including potent anti-inflammatory effects. We investigated the effects of HDL on human macrophage phenotype and the mechanisms by which these occur...|$|R
2500|$|There {{are several}} types of lipoproteins in the blood. In order of {{increasing}} density, they are chylomicrons, very-low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), low-density lipoprotein (LDL), and <b>high-density</b> <b>lipoprotein</b> (HDL). Lower protein/lipid ratios make for less dense lipoproteins. Cholesterol within different lipoproteins is identical, although some is carried as its native [...] "free" [...] alcohol form (the cholesterol-OH group facing the water surrounding the particles), while others as fatty acyl esters, known also as cholesterol esters, within the particles.|$|E
2500|$|Testosterone supplementation {{can improve}} libido in {{postmenopausal}} women, {{but can also}} reduce levels of <b>high-density</b> <b>lipoprotein</b> (good cholesterol). [...] Commercial sources for testosterone {{for women in the}} U.S. are limited, and include the commercially prepared estrogen-testosterone mixture Estratest; compounding pharmacies are the main source of testosterone-only preparations for women. A testosterone patch has been approved for use in the United Kingdom and European Union, but in Canada and the United States it awaits long-term safety data.|$|E
2500|$|Human PON1 is a {{glycoprotein}} {{composed of}} 354 amino acids {{and has a}} molecular weight of 43000 Daltons which associates with <b>high-density</b> <b>lipoprotein</b> (HDL, [...] "good cholesterol") in the circulation. Serum PON1 is secreted mainly by the liver although local synthesis occurs in several tissues and PON1 protein is found in almost all tissues. X-ray crystallography has revealed the structure of PON1 to be a 6 bladed propeller with a unique lid structure covering the active site passage and which allows association with HDL. The structure contains 2 calcium ions which are essential for catalytic activity and enzyme stability.|$|E
40|$|Liver plays a {{vital role}} in the {{production}} and catabolism of plasma lipoproteins. It depends on the integrity of cellular function of liver, which ensures homeostasis of lipid and lipoprotein metabolism. When liver cancer occurs these processes are impaired and <b>high-density</b> <b>lipoproteins</b> are changed. (C) 2007 The WJG Press. All rights reserved...|$|R
40|$|ABC ATP-binding {{cassette}} ACAT acetyl-CoA acetyltransferase apoA-I apolipoprotein A-I apoE apolipoprotein E ARF ADP-ribosylation factor ARL 7 ADP-ribosylation factor (ARF) -like 7 CE cholesteryl esters CEH cholesteryl ester hydrolase FC free cholesterol HDL <b>high-density</b> <b>lipoprotein(s)</b> LCAT lecithin-cholesterol acyltransferase LDL low-density lipoprotein(s) PL phospholipids SR-BI scavenger receptor BI Atherosclerosis {{has been}} a companion of mankind sinc...|$|R
40|$|International audienceOxidized LDLs (oxLDLs) induce various {{cellular}} dysfunctions potentially {{implicated in}} the pathogenesis of atherosclerosis. For instance, toxic concentrations of oxLDLs trigger ER stress, autophagy and apoptosis. <b>High-density</b> <b>lipoproteins</b> (HDLs) counteract several adverse biological effects triggered by oxLDLs. Our recent study reveals that HDLs inhibit the activation of ER stress and of autophagy induced by oxLDLs...|$|R
